Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism? Metabolism. 2013;62:1037–44.
Korkmaz A, Venojärvi M, Wasenius N, Manderoos S, Deruisseau KC, et al. Plasma irisin is increased following 12 weeks of Nordic walking and associates with glucose homoeostasis in overweight/obese men with impaired glucose regulation. Eur J Sport Sci. 2019;19:258–66.
De Meneck F, Victorino de Souza L, Oliveira V, do Franco MC. High irisin levels in overweight/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells. Nutr Metab Cardiovasc Dis. 2018;28:756–64.
Yosaee S, Basirat R, Hamidi A, Esteghamati A, Khodadost M, et al. Serum irisin levels in metabolically healthy versus metabolically unhealthy obesity: A case-control study. Med J Islam Repub Iran. 2020;34:46.
Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013;27:365–9.
Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96–101.
Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769–78.
Højlund K, Boström P. Irisin in obesity and type 2 diabetes. J Diabetes Complications. 2013;27:303–4.
Liu BW, Yin FZ, Qi XM, Fan DM, Zhang Y. The Levels of Serum Irisin as a Predictor of Insulin Resistance in Han Chinese Adults with Metabolically Healthy Obesity. Clin Lab. 2017;63:881–6.
Wang T, Lu J, Shi L, Chen G, Xu M, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8:115–24.
Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015;2015:421746.
Jahreis G, Kauf E, Fröhner G, Schmidt HE. Influence of intensive exercise on insulin-like growth factor 1, thyroid and steroid hormones in female gymnasts. Growth Regul. 1999;1:95–9.
Colaianni G, Notarnicola A, Sanesi L, Brunetti G, Lippo L, et al. Irisin levels correlate with bone mineral density in soccer players. J Biol Regul Homeost Agents. 2017;31:21–8.
Grygiel-Górniak B, Puszczewicz M. A review on irisin, a new protagonist that mediates muscle-adipose-bone-neuron connectivity. Eur Rev Med Pharmacol Sci. 2017;21:4687–93.
Wu LF, Zhu DC, Tang CH, Ge B, Shi J, et al. Association of Plasma Irisin with Bone Mineral Density in a Large Chinese Population Using an Extreme Sampling Design. Calcif Tissue Int. 2018;103:246–51.
Colaianni G, Errede M, Sanesi L, Notarnicola A, Celi M, et al. Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts. J Bone Miner Res. 2021;36:305–14.
Faienza MF, Brunetti G, Sanesi L, Colaianni G, Celi M, et al. High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes. Diabetes Res Clin Pract. 2018;141:10–7.
Colaianni G, Faienza MF, Sanesi L, Brunetti G, Pignataro P, et al. Irisin serum levels are positively correlated with bone mineral status in a population of healthy children. Pediatr Res. 2019;85:484–8.
Ruan Q, Huang Y, Yang L, Ruan J, Gu W, et al. The effects of both age and sex on irisin levels in paired plasma and cerebrospinal fluid in healthy humans. Peptides. 2019;113:41–51.
Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308:1150–9.
Adabimohazab R, Garfinkel A, Milam EC, Frosch O, Mangone A, et al. Does Inflammation Mediate the Association Between Obesity and Insulin Resistance? Inflammation. 2016;39:994–1003.
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127:1–4.
Colaianni G, Cuscito C, Mongelli T, Oranger A, Mori G, et al. Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol. 2014;2014:902186.
Colaianni G, Mongelli T, Cuscito C, Pignataro P, Lippo L, et al. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice. Sci Rep. 2017;7:2811.
Yan J, Liu HJ, Guo WC, Yang J. Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women. Joint Bone Spine. 2018;85:353–8.
Anastasilakis AD, Polyzos SA, Makras P, Gkiomisi A, Bisbinas I, Katsarou A, et al. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months. Osteoporos Int. 2014;25:633–1642.
Palermo A, Strollo R, Maddaloni E, Tuccinardi D, D’Onofrio L, et al. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf). 2015;82:615–9.
Qiao X, Nie Y, Ma Y, Chen Y, Cheng R, et al. Corrigendum: Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016;6:21053.
Ma Y, Qiao X, Zeng R, Cheng R, Zhang J, et al. Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells. FASEB J. 2018;17:fj201700983RR.
Estell EG, Le PT, Vegting Y, Kim H, Wrann C, et al. Irisin directly stimulates osteoclastogenesis and bone resorption in vitro and in vivo. Elife. 2020;9:e58172.
Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, et al. Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. Cell. 2018;175:1756–68.